Publication | Closed Access

Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection

Health SciencesSkin Structure InfectionOral Amoxicillin-clavulanatePharmacologyTopical DrugAntimicrobial ChemotherapyDermatologyMedicineClinical MicrobiologyAntimicrobial ResistanceSequential Intravenous/oral MoxifloxacinDrug Resistance